Most Read
After two years of working from home, many women are no longer willing to endure painful footwear
KKR Sees ‘Golden’ Chance to Snap Up Risky Debt Amid Market Chaos
US, Iran Face a Deadline After Nuclear Talks End Without Agreement
Carlyle CEO Resigns in Sudden Reversal of Generational Shift
Michael R. Bloomberg: Military Recruitment Woes Endanger National Security
The US is facing a shortfall of troops. Here’s how to solve the problem.
Opinion
Crypto's Limp BlackRock Response Is a Clear Tell
If not even a vote of confidence from the world’s largest asset manager can spark a rally, then the bear market is far from over.
How We Get From ‘Great Resignation’ to Rate Hikes
And a few other connections, like inflation dynamics, China investor wariness, and the Thucydides Trap over Taiwan. Plus: Italy’s worsening crisis. And jirds.
Don’t Call It a Windfall Tax
The US Senate’s IRA package puts a levy on buybacks that companies may view differently.
SoftBank’s Shogun Has a Rare Moment of Contrition
Masayoshi Son once compared himself to Jesus Christ. After a $23 billion loss, he says he’s like a defeated feudal lord.
Pharma Overpromised on Antidepressants
Two new studies show that SSRIs don’t treat depression by fixing a chemical imbalance in the brain.
Most Read
After two years of working from home, many women are no longer willing to endure painful footwear
Opinion
Crypto's Limp BlackRock Response Is a Clear Tell
If not even a vote of confidence from the world’s largest asset manager can spark a rally, then the bear market is far from over.
How We Get From ‘Great Resignation’ to Rate Hikes
And a few other connections, like inflation dynamics, China investor wariness, and the Thucydides Trap over Taiwan. Plus: Italy’s worsening crisis. And jirds.
Don’t Call It a Windfall Tax
The US Senate’s IRA package puts a levy on buybacks that companies may view differently.
SoftBank’s Shogun Has a Rare Moment of Contrition
Masayoshi Son once compared himself to Jesus Christ. After a $23 billion loss, he says he’s like a defeated feudal lord.
Pharma Overpromised on Antidepressants
Two new studies show that SSRIs don’t treat depression by fixing a chemical imbalance in the brain.